QIAGEN N.V. Cost-method Investments, Other than Temporary Impairment
QIAGEN N.V. (QGEN) reported Cost-method Investments, Other than Temporary Impairment of $5.10 million for the 12-month period ending 2017-12-31, per its 20-F filed 2018-03-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostmethodInvestmentsOtherThanTemporaryImpairment · last filed 2018-03-06
| Period end | Cost-method Investments, Other than Temporary Impairment 12 month |
|---|---|
| 2017-12-31 | $5.10M 20-F · filed 2018-03-06 |
| 2015-12-31 | $2.20M 20-F · filed 2018-03-06 |
| 2014-12-31 | $6.00M 20-F · filed 2017-03-06 |
| 2013-12-31 | $3.40M 20-F · filed 2014-03-03 |
| 2012-12-31 | $3.40M 20-F · filed 2014-03-03 |